169 related articles for article (PubMed ID: 35514133)
1. Quiescence regulation by normal haematopoietic stem cells and leukaemia stem cells.
Gudmundsson KO; Du Y
FEBS J; 2023 Aug; 290(15):3708-3722. PubMed ID: 35514133
[TBL] [Abstract][Full Text] [Related]
2. Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia.
Grenier JMP; Testut C; Fauriat C; Mancini SJC; Aurrand-Lions M
Front Immunol; 2021; 12():756231. PubMed ID: 34867994
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities.
O'Reilly E; Zeinabad HA; Szegezdi E
Blood Rev; 2021 Nov; 50():100850. PubMed ID: 34049731
[TBL] [Abstract][Full Text] [Related]
4. HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML.
Li Z; Wang F; Tian X; Long J; Ling B; Zhang W; Xu J; Liang A
J Exp Clin Cancer Res; 2021 Jun; 40(1):210. PubMed ID: 34167558
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
[TBL] [Abstract][Full Text] [Related]
6. Regulation of hematopoietic and leukemic stem cells by the immune system.
Riether C; Schürch CM; Ochsenbein AF
Cell Death Differ; 2015 Feb; 22(2):187-98. PubMed ID: 24992931
[TBL] [Abstract][Full Text] [Related]
7. Revisiting CLEC12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy.
Bill M; Aggerholm A; Kjeldsen E; Roug AS; Hokland P; Nederby L
Br J Haematol; 2019 Mar; 184(5):769-781. PubMed ID: 30520015
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis.
Yamashita M; Dellorusso PV; Olson OC; Passegué E
Nat Rev Cancer; 2020 Jul; 20(7):365-382. PubMed ID: 32415283
[TBL] [Abstract][Full Text] [Related]
9. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.
Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH
J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748
[TBL] [Abstract][Full Text] [Related]
11. ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia.
Mohd Amin A; Panneerselvan N; Md Noor S; Mohtaruddin N; Sathar J; Norbaya WS; Osman R; Kee LH; Mohd Yaakub WH; Cheong SK; Abdullah M
Malays J Pathol; 2023 Apr; 45(1):65-76. PubMed ID: 37119247
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CK2{alpha} and PI3K/Akt synergistically induces apoptosis of CD34+CD38- leukaemia cells while sparing haematopoietic stem cells.
Cheong JW; Min YH; Eom JI; Kim SJ; Jeung HK; Kim JS
Anticancer Res; 2010 Nov; 30(11):4625-34. PubMed ID: 21115916
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia.
Chen L; Fan X; Zhu J; Chen X; Liu Y; Zhou H
RNA Biol; 2020 Jun; 17(6):784-793. PubMed ID: 32174258
[TBL] [Abstract][Full Text] [Related]
14. The leukemic stem cell niche: current concepts and therapeutic opportunities.
Lane SW; Scadden DT; Gilliland DG
Blood; 2009 Aug; 114(6):1150-7. PubMed ID: 19401558
[TBL] [Abstract][Full Text] [Related]
15. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
Lefort S; Maguer-Satta V
Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
[TBL] [Abstract][Full Text] [Related]
16. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
Marchand T; Pinho S
Front Immunol; 2021; 12():775128. PubMed ID: 34721441
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.
Zhang B; Nguyen LXT; Li L; Zhao D; Kumar B; Wu H; Lin A; Pellicano F; Hopcroft L; Su YL; Copland M; Holyoake TL; Kuo CJ; Bhatia R; Snyder DS; Ali H; Stein AS; Brewer C; Wang H; McDonald T; Swiderski P; Troadec E; Chen CC; Dorrance A; Pullarkat V; Yuan YC; Perrotti D; Carlesso N; Forman SJ; Kortylewski M; Kuo YH; Marcucci G
Nat Med; 2018 May; 24(4):450-462. PubMed ID: 29505034
[TBL] [Abstract][Full Text] [Related]
18. Recreating the Bone Marrow Microenvironment to Model Leukemic Stem Cell Quiescence.
O'Reilly E; Zeinabad HA; Nolan C; Sefy J; Williams T; Tarunina M; Hernandez D; Choo Y; Szegezdi E
Front Cell Dev Biol; 2021; 9():662868. PubMed ID: 34589478
[TBL] [Abstract][Full Text] [Related]
19. Lipids and the cancer stemness regulatory system in acute myeloid leukemia.
Lim INX; Nagree MS; Xie SZ
Essays Biochem; 2022 Sep; 66(4):333-344. PubMed ID: 35996953
[TBL] [Abstract][Full Text] [Related]
20. Regulation of hematopoietic and leukemia stem cells by regulatory T cells.
Riether C
Front Immunol; 2022; 13():1049301. PubMed ID: 36405718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]